Bay Street News, May, 2020

MORRIS PLAINS, N.J., May 13, 2020 (GLOBE NEWSWIRE) — Immunomedics, Inc., (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical […]

CALGARY, Alberta, May 13, 2020 (GLOBE NEWSWIRE) — Zargon Oil & Gas Ltd. (“Zargon” or the “Company”) announces that it […]

BURLINGTON, Mass., May 13, 2020 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and […]

SAN DIEGO, May 13, 2020 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing […]

TORONTO, May 13, 2020 (GLOBE NEWSWIRE) — SMTC Corporation (Nasdaq:SMTX), a global electronics manufacturing services provider and winner of the […]

Promising clinical research supports Xoft brain IORT as a viable treatment option for glioblastoma multiforme that may extend patients’ livesOverall […]

SOUTH SAN FRANCISCO, Calif., May 13, 2020 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused […]

HOUSTON, May 13, 2020 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize™ liposomal […]

ALLO-501 in Combination with ALLO-647 Based Lymphodepletion Regimen was Well Tolerated With No Dose-Limiting Toxicities or Evidence of Graft-vs-Host DiseaseAbstract […]

($US except where otherwise noted)NEWMARKET, Ontario, May 13, 2020 (GLOBE NEWSWIRE) —Recent HighlightsGrew net sales by 14.1% versus the prior […]